Innospec Key Executives
This section highlights Innospec's key executives, including their titles and compensation details.
Find Contacts at Innospec
(Showing 0 of )
Innospec Earnings
This section highlights Innospec's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Last Earnings Results
Earnings Call Transcripts
Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
---|---|---|---|---|---|
Read Transcript | Q4 | 2024 | 2025-02-19 | N/A | N/A |
Read Transcript | Q3 | 2024 | 2024-11-06 | N/A | N/A |
Read Transcript | Q2 | 2024 | 2024-08-07 | N/A | N/A |
Read Transcript | Q1 | 2024 | 2024-05-10 | N/A | N/A |
Read Transcript | Q4 | 2023 | 2024-02-14 | N/A | N/A |
Read Transcript | Q3 | 2023 | 2023-11-08 | N/A | N/A |
Read Transcript | Q2 | 2023 | 2023-08-09 | N/A | N/A |
Read Transcript | Q1 | 2023 | 2023-05-06 | N/A | N/A |

Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in various fuels. This segment's products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. Its Performance Chemicals segment provides technology-based solutions for its customers' processes or products that focuses on the personal care, home care, agrochemical, and metal extraction markets. The company's Oilfield Services segment develops and markets chemical solutions for fracturing, stimulation, and completion operations; and products for oil and gas production, as well as products to prevent loss of mud in drilling operations. It sells its products primarily to oil and gas exploration and production companies, oil refineries, fuel manufacturers and users, personal care and home care companies, formulators of agrochemical and metal extraction formulations, and other chemical and industrial companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado.
$96.01
Stock Price
$2.40B
Market Cap
2.45K
Employees
Englewood, CO
Location
Financial Statements
Access annual & quarterly financial statements for Innospec, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
---|---|---|---|---|---|
Revenue | $1.85B | $1.95B | $1.96B | $1.48B | $1.19B |
Cost of Revenue | $1.30B | $1.36B | $1.38B | $1.05B | $850.40M |
Gross Profit | $542.90M | $591.10M | $586.70M | $434.90M | $342.70M |
Gross Profit Ratio | 29.42% | 30.30% | 29.88% | 29.30% | 28.72% |
Research and Development Expenses | $47.80M | $41.70M | $38.70M | $37.40M | $30.90M |
General and Administrative Expenses | $- | $- | $- | $- | $- |
Selling and Marketing Expenses | $- | $- | $- | $- | $- |
Selling General and Administrative Expenses | $314.00M | $387.80M | $360.70M | $267.20M | $237.00M |
Other Expenses | $3.20M | $- | $-1.60M | $3.80M | $7.80M |
Operating Expenses | $365.00M | $429.50M | $399.40M | $304.60M | $267.90M |
Cost and Expenses | $1.67B | $1.79B | $1.78B | $1.35B | $1.12B |
Interest Income | $- | $2.30M | $1.10M | $1.50M | $1.80M |
Interest Expense | $- | $- | $1.10M | $1.50M | $1.80M |
Depreciation and Amortization | $43.50M | $39.30M | $45.00M | $46.20M | $50.70M |
EBITDA | $224.60M | $200.90M | $187.30M | $182.10M | $92.20M |
EBITDA Ratio | 12.17% | 10.31% | 11.50% | 11.92% | 10.78% |
Operating Income | $177.90M | $161.60M | $187.30M | $132.10M | $82.60M |
Operating Income Ratio | 9.64% | 8.29% | 9.54% | 8.91% | 6.92% |
Total Other Income Expenses Net | $-136.70M | $12.80M | $-2.70M | $2.30M | $-35.10M |
Income Before Tax | $41.20M | $174.40M | $184.60M | $134.40M | $39.70M |
Income Before Tax Ratio | 2.23% | 8.95% | 9.40% | 9.06% | 3.33% |
Income Tax Expense | $5.60M | $35.30M | $51.60M | $41.30M | $11.00M |
Net Income | $35.60M | $139.10M | $133.00M | $93.10M | $28.70M |
Net Income Ratio | 1.93% | 7.14% | 6.77% | 6.28% | 2.41% |
EPS | $1.43 | $5.60 | $5.37 | $3.78 | $1.17 |
EPS Diluted | $1.42 | $5.56 | $5.32 | $3.75 | $1.16 |
Weighted Average Shares Outstanding | 24.93M | 24.85M | 24.79M | 24.65M | 24.56M |
Weighted Average Shares Outstanding Diluted | 25.12M | 25.02M | 24.98M | 24.85M | 24.78M |
SEC Filing | Source | Source | Source | Source | Source |
Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $466.80M | $443.40M | $435.00M | $500.20M | $494.70M | $464.10M | $480.40M | $509.60M | $510.70M | $513.00M | $467.60M | $472.40M | $413.20M | $376.10M | $354.50M | $339.60M | $310.80M | $265.10M | $244.90M | $372.30M |
Cost of Revenue | $330.60M | $319.30M | $308.10M | $344.50M | $339.00M | $326.90M | $330.00M | $361.80M | $359.10M | $357.00M | $327.80M | $333.10M | $300.30M | $263.20M | $246.20M | $238.80M | $219.80M | $186.40M | $185.80M | $258.40M |
Gross Profit | $136.20M | $124.10M | $126.90M | $155.70M | $155.70M | $137.20M | $150.40M | $147.80M | $151.60M | $156.00M | $139.80M | $139.30M | $112.90M | $112.90M | $108.30M | $100.80M | $91.00M | $78.70M | $59.10M | $113.90M |
Gross Profit Ratio | 29.18% | 28.00% | 29.20% | 31.10% | 31.50% | 29.60% | 31.30% | 29.00% | 29.70% | 30.40% | 29.90% | 29.50% | 27.30% | 30.00% | 30.60% | 29.70% | 29.28% | 29.69% | 24.13% | 30.59% |
Research and Development Expenses | $12.70M | $11.10M | $12.20M | $11.80M | $8.90M | $11.60M | $10.60M | $10.60M | $8.40M | $10.10M | $10.10M | $10.10M | $9.50M | $10.30M | $8.60M | $9.00M | $6.50M | $7.70M | $8.10M | $8.60M |
General and Administrative Expenses | $- | $65.10M | $71.80M | $91.00M | $- | $- | $103.90M | $94.50M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Selling and Marketing Expenses | $- | $1.70M | $1.60M | $1.70M | $- | $- | $1.70M | $1.70M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Selling General and Administrative Expenses | $81.10M | $66.80M | $73.40M | $92.70M | $101.00M | $83.70M | $105.60M | $96.20M | $96.60M | $95.80M | $83.40M | $84.90M | $69.70M | $71.20M | $62.70M | $63.60M | $54.90M | $54.20M | $63.50M | $64.40M |
Other Expenses | $- | $- | $- | $- | $1.70M | $4.80M | $2.70M | $3.70M | $-1.40M | $1.20M | $-3.60M | $1.30M | $-2.40M | $-200.00K | $3.40M | $3.00M | $- | $3.80M | $100.00K | $3.90M |
Operating Expenses | $93.80M | $77.90M | $85.60M | $104.50M | $109.90M | $95.30M | $116.20M | $106.80M | $105.00M | $105.90M | $93.50M | $95.00M | $79.20M | $81.50M | $71.30M | $72.60M | $61.40M | $61.90M | $71.60M | $73.00M |
Cost and Expenses | $424.40M | $397.20M | $393.70M | $449.00M | $448.90M | $422.20M | $446.20M | $468.60M | $464.10M | $462.90M | $421.30M | $428.10M | $379.50M | $344.70M | $317.50M | $311.40M | $281.20M | $248.30M | $257.40M | $331.40M |
Interest Income | $- | $- | $- | $2.10M | $1.50M | $800.00K | $300.00K | $300.00K | $- | $300.00K | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Interest Expense | $- | $- | $2.10M | $- | $900.00K | $800.00K | $300.00K | $300.00K | $- | $300.00K | $400.00K | $400.00K | $400.00K | $400.00K | $300.00K | $400.00K | $300.00K | $400.00K | $500.00K | $600.00K |
Depreciation and Amortization | $10.90M | $11.10M | $11.10M | $10.40M | $10.20M | $9.90M | $9.90M | $9.30M | $14.10M | $10.10M | $10.30M | $10.50M | $15.30M | $10.30M | $10.30M | $10.30M | $10.70M | $11.10M | $12.20M | $12.00M |
EBITDA | $48.30M | $55.90M | $54.80M | $63.30M | $56.00M | $53.60M | $45.80M | $52.00M | $59.30M | $60.20M | $53.00M | $54.80M | $46.70M | $41.50M | $50.70M | $41.50M | $39.70M | $31.70M | $-41.00M | $56.80M |
EBITDA Ratio | 10.35% | 12.61% | 12.05% | 12.32% | 11.32% | 11.16% | 9.74% | 9.87% | 8.85% | 11.97% | 9.13% | 11.88% | 7.58% | 11.03% | 14.30% | 12.22% | 12.97% | 7.77% | -0.08% | 15.26% |
Operating Income | $41.10M | $45.60M | $41.30M | $51.20M | $45.80M | $41.90M | $34.20M | $41.00M | $36.00M | $50.10M | $32.40M | $44.30M | $35.50M | $31.40M | $37.00M | $28.20M | $29.40M | $16.80M | $-53.40M | $40.90M |
Operating Income Ratio | 8.80% | 10.28% | 9.49% | 10.24% | 9.26% | 9.03% | 7.12% | 8.05% | 7.05% | 9.77% | 6.93% | 9.38% | 8.59% | 8.35% | 10.44% | 8.30% | 9.46% | 6.34% | -21.80% | 10.99% |
Total Other Income Expenses Net | $-143.70M | $-800.00K | $2.40M | $2.40M | $-8.90M | $5.60M | $2.40M | $4.00M | $-1.40M | $-1.20M | $-4.00M | $3.90M | $-2.80M | $-600.00K | $3.10M | $2.60M | $-300.00K | $3.40M | $-400.00K | $3.30M |
Income Before Tax | $-102.60M | $44.80M | $43.70M | $55.30M | $45.30M | $47.50M | $36.60M | $45.00M | $45.20M | $48.90M | $42.30M | $48.20M | $32.70M | $30.80M | $40.10M | $30.80M | $29.10M | $20.20M | $-53.80M | $44.20M |
Income Before Tax Ratio | -21.98% | 10.10% | 10.05% | 11.06% | 9.16% | 10.23% | 7.62% | 8.83% | 8.85% | 9.53% | 9.05% | 10.20% | 7.91% | 8.19% | 11.31% | 9.07% | 9.36% | 7.62% | -21.97% | 11.87% |
Income Tax Expense | $-32.20M | $11.40M | $12.50M | $13.90M | $7.50M | $8.30M | $7.70M | $11.80M | $19.70M | $10.20M | $10.00M | $11.70M | $8.80M | $7.40M | $17.70M | $7.40M | $6.50M | $7.50M | $-14.10M | $11.10M |
Net Income | $-70.40M | $33.40M | $31.20M | $41.40M | $37.80M | $39.20M | $28.90M | $33.20M | $25.50M | $38.70M | $32.30M | $36.50M | $23.90M | $23.40M | $22.40M | $23.40M | $22.60M | $12.70M | $-39.70M | $33.10M |
Net Income Ratio | -15.08% | 7.53% | 7.17% | 8.28% | 7.64% | 8.45% | 6.02% | 6.51% | 4.99% | 7.54% | 6.91% | 7.73% | 5.78% | 6.22% | 6.32% | 6.89% | 7.27% | 4.79% | -16.21% | 8.89% |
EPS | $-2.82 | $1.34 | $1.25 | $1.66 | $1.52 | $1.58 | $1.16 | $1.34 | $1.03 | $1.56 | $1.30 | $1.47 | $0.97 | $0.95 | $0.91 | $0.95 | $0.92 | $0.52 | $-1.62 | $1.35 |
EPS Diluted | $-2.80 | $1.33 | $1.24 | $1.65 | $1.51 | $1.57 | $1.16 | $1.33 | $1.02 | $1.55 | $1.29 | $1.46 | $0.96 | $0.94 | $0.90 | $0.94 | $0.91 | $0.51 | $-1.62 | $1.34 |
Weighted Average Shares Outstanding | 24.95M | 24.94M | 24.94M | 24.89M | 24.87M | 24.87M | 24.87M | 24.80M | 24.77M | 24.79M | 24.80M | 24.79M | 24.72M | 24.64M | 24.63M | 24.60M | 24.59M | 24.57M | 24.51M | 24.53M |
Weighted Average Shares Outstanding Diluted | 25.11M | 25.10M | 25.10M | 25.07M | 25.03M | 25.01M | 24.98M | 24.96M | 24.96M | 24.96M | 24.97M | 24.96M | 24.89M | 24.86M | 24.87M | 24.84M | 24.76M | 24.72M | 24.56M | 24.74M |
SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
---|---|---|---|---|---|
Cash and Cash Equivalents | $289.20M | $203.70M | $147.10M | $141.80M | $105.30M |
Short Term Investments | $- | $- | $- | $- | $- |
Cash and Short Term Investments | $289.20M | $203.70M | $147.10M | $141.80M | $105.30M |
Net Receivables | $341.70M | $359.80M | $334.60M | $284.50M | $221.40M |
Inventory | $301.00M | $300.10M | $373.10M | $277.60M | $220.00M |
Other Current Assets | $24.70M | $22.10M | $17.80M | $24.20M | $19.50M |
Total Current Assets | $956.60M | $885.70M | $872.60M | $728.10M | $566.20M |
Property Plant Equipment Net | $314.50M | $313.40M | $266.20M | $249.80M | $250.90M |
Goodwill | $382.50M | $399.30M | $358.80M | $364.30M | $371.20M |
Intangible Assets | $65.40M | $57.30M | $45.00M | $57.50M | $75.30M |
Goodwill and Intangible Assets | $447.90M | $456.60M | $403.80M | $421.80M | $446.50M |
Long Term Investments | $- | $- | $- | $159.80M | $118.00M |
Tax Assets | $9.40M | $10.40M | $5.90M | $6.40M | $7.60M |
Other Non-Current Assets | $6.30M | $41.30M | $55.20M | $5.00M | $8.20M |
Total Non-Current Assets | $778.10M | $821.70M | $731.10M | $842.80M | $831.20M |
Other Assets | $- | $- | $- | $- | $- |
Total Assets | $1.73B | $1.71B | $1.60B | $1.57B | $1.40B |
Account Payables | $163.80M | $163.60M | $165.30M | $148.70M | $98.70M |
Short Term Debt | $13.90M | $13.60M | $27.80M | $12.50M | $11.80M |
Tax Payables | $3.10M | $2.60M | $18.40M | $3.70M | $5.50M |
Deferred Revenue | $- | $- | $- | $- | $- |
Other Current Liabilities | $190.60M | $191.70M | $194.30M | $171.70M | $136.40M |
Total Current Liabilities | $371.40M | $371.50M | $405.80M | $336.60M | $252.40M |
Long Term Debt | $31.00M | $31.60M | $62.80M | $46.20M | $29.00M |
Deferred Revenue Non-Current | $- | $- | $- | $99.70M | $104.80M |
Deferred Tax Liabilities Non-Current | $23.50M | $33.50M | $26.20M | $60.80M | $46.90M |
Other Non-Current Liabilities | $92.70M | $121.20M | $68.50M | $94.30M | $124.20M |
Total Non-Current Liabilities | $147.20M | $186.30M | $157.50M | $201.30M | $200.10M |
Other Liabilities | $- | $- | $- | $- | $- |
Total Liabilities | $518.60M | $557.80M | $563.30M | $537.90M | $452.50M |
Preferred Stock | $- | $- | $- | $- | $- |
Common Stock | $300.00K | $300.00K | $300.00K | $300.00K | $300.00K |
Retained Earnings | $1.02B | $1.03B | $924.20M | $822.90M | $758.60M |
Accumulated Other Comprehensive Income Loss | $-91.00M | $-148.10M | $-145.20M | $-46.90M | $-57.30M |
Other Total Stockholders Equity | $276.90M | $266.70M | $258.70M | $256.10M | $242.80M |
Total Stockholders Equity | $1.21B | $1.15B | $1.04B | $1.03B | $944.90M |
Total Equity | $1.22B | $1.15B | $1.04B | $1.03B | $945.40M |
Total Liabilities and Stockholders Equity | $1.73B | $1.71B | $1.60B | $1.57B | $1.40B |
Minority Interest | $4.90M | $2.50M | $2.40M | $600.00K | $500.00K |
Total Liabilities and Total Equity | $1.73B | $1.71B | $1.60B | $1.57B | $1.40B |
Total Investments | $- | $- | $- | $159.80M | $118.00M |
Total Debt | $44.90M | $45.20M | $45.30M | $35.60M | $40.80M |
Net Debt | $-244.30M | $-158.50M | $-101.80M | $-106.20M | $-64.50M |
Balance Sheet Charts
Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash and Cash Equivalents | $289.20M | $303.80M | $240.20M | $270.10M | $203.70M | $207.20M | $165.90M | $147.50M | $147.10M | $100.50M | $71.40M | $105.60M | $141.80M | $89.20M | $94.40M | $117.00M | $105.30M | $66.60M | $58.20M | $68.10M |
Short Term Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Cash and Short Term Investments | $289.20M | $303.80M | $240.20M | $270.10M | $203.70M | $207.20M | $165.90M | $147.50M | $147.10M | $100.50M | $71.40M | $105.60M | $141.80M | $89.20M | $94.40M | $117.00M | $105.30M | $66.60M | $58.20M | $68.10M |
Net Receivables | $341.70M | $327.60M | $300.30M | $318.20M | $359.80M | $305.20M | $310.90M | $342.40M | $334.60M | $342.50M | $339.90M | $337.70M | $284.50M | $302.80M | $281.60M | $247.90M | $221.40M | $206.20M | $213.40M | $296.30M |
Inventory | $301.00M | $319.30M | $313.50M | $304.30M | $300.10M | $331.50M | $356.70M | $365.70M | $373.10M | $381.80M | $362.20M | $308.20M | $277.60M | $274.10M | $250.50M | $223.10M | $220.00M | $239.80M | $243.60M | $246.00M |
Other Current Assets | $24.70M | $14.90M | $22.80M | $20.30M | $22.10M | $19.80M | $21.00M | $19.40M | $17.80M | $21.60M | $25.80M | $27.10M | $24.20M | $16.90M | $16.60M | $19.60M | $19.50M | $16.20M | $17.70M | $16.30M |
Total Current Assets | $956.60M | $965.60M | $876.80M | $912.90M | $885.70M | $863.70M | $854.50M | $875.00M | $872.60M | $846.40M | $799.30M | $778.60M | $728.10M | $683.00M | $643.10M | $607.60M | $566.20M | $528.80M | $532.90M | $626.70M |
Property Plant Equipment Net | $314.50M | $323.70M | $319.80M | $312.20M | $313.40M | $287.10M | $288.20M | $282.60M | $266.20M | $252.50M | $259.00M | $256.00M | $249.80M | $246.40M | $250.50M | $246.60M | $250.90M | $233.90M | $228.40M | $229.50M |
Goodwill | $382.50M | $392.30M | $388.20M | $397.50M | $399.30M | $357.90M | $360.60M | $360.20M | $358.80M | $351.70M | $357.00M | $362.00M | $364.30M | $366.00M | $368.20M | $367.20M | $371.20M | $367.20M | $363.30M | $361.20M |
Intangible Assets | $65.40M | $63.60M | $61.40M | $57.70M | $57.30M | $47.80M | $46.70M | $46.90M | $45.00M | $43.60M | $48.10M | $53.00M | $57.50M | $61.90M | $66.40M | $70.20M | $75.30M | $78.60M | $82.30M | $107.10M |
Goodwill and Intangible Assets | $447.90M | $455.90M | $449.60M | $455.20M | $456.60M | $405.70M | $407.30M | $407.10M | $403.80M | $395.30M | $405.10M | $415.00M | $421.80M | $427.90M | $434.60M | $437.40M | $446.50M | $445.80M | $445.60M | $468.30M |
Long Term Investments | $- | $- | $- | $- | $- | $49.70M | $49.10M | $- | $- | $- | $- | $- | $159.80M | $122.80M | $121.20M | $119.60M | $118.00M | $120.00M | $118.60M | $117.30M |
Tax Assets | $9.40M | $10.50M | $10.40M | $10.40M | $10.40M | $5.90M | $5.90M | $5.90M | $5.90M | $5.70M | $6.00M | $6.20M | $6.40M | $7.30M | $7.40M | $7.40M | $7.60M | $9.40M | $8.90M | $8.80M |
Other Non-Current Assets | $6.30M | $42.00M | $43.70M | $42.10M | $41.30M | $6.50M | $5.80M | $53.50M | $55.20M | $169.30M | $168.50M | $168.00M | $5.00M | $5.00M | $5.00M | $7.50M | $8.20M | $5.80M | $4.60M | $4.70M |
Total Non-Current Assets | $778.10M | $832.10M | $823.50M | $819.90M | $821.70M | $754.90M | $756.30M | $749.10M | $731.10M | $822.80M | $838.60M | $845.20M | $842.80M | $809.40M | $818.70M | $818.50M | $831.20M | $814.90M | $806.10M | $828.60M |
Other Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $0 | $- | $- | $- | $- |
Total Assets | $1.73B | $1.80B | $1.70B | $1.73B | $1.71B | $1.62B | $1.61B | $1.62B | $1.60B | $1.67B | $1.64B | $1.62B | $1.57B | $1.49B | $1.46B | $1.43B | $1.40B | $1.34B | $1.34B | $1.46B |
Account Payables | $163.80M | $169.00M | $147.70M | $166.40M | $163.60M | $146.10M | $157.90M | $177.70M | $165.30M | $173.60M | $180.90M | $161.80M | $148.70M | $137.10M | $123.50M | $114.50M | $98.70M | $81.80M | $74.10M | $108.40M |
Short Term Debt | $13.90M | $14.00M | $14.90M | $13.60M | $27.20M | $13.10M | $14.30M | $15.20M | $13.90M | $13.60M | $14.10M | $14.10M | $12.50M | $13.30M | $12.30M | $12.60M | $11.80M | $11.70M | $11.60M | $11.90M |
Tax Payables | $3.10M | $5.10M | $21.30M | $12.20M | $2.60M | $15.20M | $13.70M | $20.20M | $18.40M | $14.70M | $15.10M | $13.70M | $3.70M | $4.60M | $6.30M | $8.80M | $5.50M | $5.40M | $8.40M | $12.30M |
Deferred Revenue | $- | $- | $21.30M | $12.20M | $2.80M | $- | $9.80M | $- | $- | $- | $- | $- | $- | $4.60M | $6.30M | $8.80M | $5.50M | $5.40M | $8.40M | $12.30M |
Other Current Liabilities | $190.60M | $185.00M | $148.90M | $172.70M | $178.10M | $169.80M | $179.00M | $168.50M | $208.20M | $179.50M | $159.10M | $162.70M | $171.70M | $153.30M | $148.90M | $138.40M | $136.40M | $130.90M | $125.10M | $133.50M |
Total Current Liabilities | $371.40M | $373.10M | $332.80M | $364.90M | $371.50M | $344.20M | $364.90M | $381.60M | $405.80M | $381.40M | $369.20M | $352.30M | $336.60M | $308.30M | $291.00M | $274.30M | $252.40M | $229.80M | $219.20M | $266.10M |
Long Term Debt | $31.00M | $31.70M | $33.20M | $30.00M | $63.20M | $29.40M | $31.60M | $33.80M | $31.40M | $32.10M | $35.20M | $28.30M | $23.10M | $20.20M | $24.40M | $49.20M | $29.00M | $18.70M | $57.60M | $79.80M |
Deferred Revenue Non-Current | $- | $- | $-1 | $- | $-1 | $89.00M | $90.60M | $- | $- | $- | $- | $- | $99.70M | $97.70M | $99.10M | $103.20M | $104.80M | $103.80M | $101.90M | $97.30M |
Deferred Tax Liabilities Non-Current | $23.50M | $35.80M | $35.40M | $34.10M | $33.50M | $26.40M | $27.30M | $27.40M | $26.20M | $59.70M | $60.80M | $61.30M | $60.80M | $54.40M | $54.40M | $46.50M | $46.90M | $47.20M | $44.00M | $49.90M |
Other Non-Current Liabilities | $92.70M | $109.50M | $103.00M | $117.60M | $89.60M | $90.50M | $92.20M | $100.70M | $99.90M | $104.10M | $104.10M | $113.00M | $117.40M | $116.40M | $117.80M | $97.00M | $124.20M | $122.00M | $118.50M | $115.20M |
Total Non-Current Liabilities | $147.20M | $177.00M | $171.60M | $181.70M | $186.30M | $146.30M | $151.10M | $161.90M | $157.50M | $195.90M | $200.10M | $202.60M | $201.30M | $191.00M | $196.60M | $192.70M | $200.10M | $187.90M | $220.10M | $244.90M |
Other Liabilities | $- | $- | $1 | $- | $1 | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Liabilities | $518.60M | $550.10M | $504.40M | $546.60M | $557.80M | $490.50M | $516.00M | $543.50M | $563.30M | $577.30M | $569.30M | $554.90M | $537.90M | $499.30M | $487.60M | $467.00M | $452.50M | $417.70M | $439.30M | $511.00M |
Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $600.00K | $- | $- | $- | $500.00K | $500.00K | $- | $- |
Common Stock | $- | $300.00K | $300.00K | $300.00K | $300.00K | $300.00K | $300.00K | $300.00K | $300.00K | $300.00K | $300.00K | $300.00K | $300.00K | $300.00K | $300.00K | $300.00K | $300.00K | $300.00K | $300.00K | $300.00K |
Retained Earnings | $- | $1.12B | $1.08B | $1.07B | $1.03B | $1.01B | $969.10M | $957.40M | $924.20M | $914.80M | $876.10M | $859.40M | $822.90M | $813.80M | $790.40M | $782.00M | $758.60M | $748.80M | $736.10M | $788.60M |
Accumulated Other Comprehensive Income Loss | $- | $-145.30M | $-160.60M | $-155.40M | $-148.10M | $-147.90M | $-139.70M | $-140.80M | $-145.20M | $-83.30M | $-67.10M | $-50.50M | $-46.90M | $-69.90M | $-63.50M | $-67.90M | $-57.30M | $-64.30M | $-76.40M | $-82.30M |
Other Total Stockholders Equity | $1.31B | $273.20M | $271.10M | $269.10M | $266.70M | $267.40M | $262.50M | $263.70M | $258.70M | $257.60M | $259.30M | $259.00M | $256.10M | $248.30M | $246.40M | $244.20M | $242.80M | $240.70M | $239.20M | $237.20M |
Total Stockholders Equity | $1.31B | $1.24B | $1.19B | $1.18B | $1.15B | $1.13B | $1.09B | $1.08B | $1.04B | $1.09B | $1.07B | $1.07B | $1.03B | $992.50M | $973.60M | $958.60M | $944.90M | $926.00M | $899.20M | $943.80M |
Total Equity | $1.31B | $1.25B | $1.20B | $1.19B | $1.15B | $1.13B | $1.10B | $1.08B | $1.04B | $1.09B | $1.07B | $1.07B | $1.03B | $993.10M | $974.20M | $959.10M | $945.40M | $926.50M | $899.70M | $944.30M |
Total Liabilities and Stockholders Equity | $1.73B | $1.80B | $1.70B | $1.73B | $1.71B | $1.62B | $1.61B | $1.62B | $1.60B | $1.67B | $1.64B | $1.62B | $1.57B | $1.49B | $1.46B | $1.43B | $1.40B | $1.34B | $1.34B | $1.46B |
Minority Interest | $- | $4.20M | $3.30M | $2.60M | $2.50M | $2.70M | $2.60M | $2.40M | $2.40M | $2.50M | $700.00K | $700.00K | $600.00K | $600.00K | $600.00K | $500.00K | $500.00K | $500.00K | $500.00K | $500.00K |
Total Liabilities and Total Equity | $1.73B | $1.80B | $1.70B | $1.73B | $1.71B | $1.62B | $1.61B | $1.62B | $1.60B | $1.67B | $1.64B | $1.62B | $1.57B | $1.49B | $1.46B | $1.43B | $1.40B | $1.34B | $1.34B | $1.46B |
Total Investments | $- | $- | $- | $- | $- | $49.70M | $49.10M | $- | $- | $- | $- | $- | $159.80M | $122.80M | $121.20M | $119.60M | $118.00M | $120.00M | $118.60M | $117.30M |
Total Debt | $44.90M | $45.70M | $48.10M | $43.60M | $45.20M | $42.50M | $45.90M | $49.00M | $45.30M | $45.70M | $49.30M | $42.40M | $35.60M | $33.50M | $36.70M | $37.20M | $40.80M | $30.40M | $69.20M | $91.70M |
Net Debt | $-244.30M | $-258.10M | $-192.10M | $-226.50M | $-158.50M | $-164.70M | $-120.00M | $-98.50M | $-101.80M | $-54.80M | $-22.10M | $-63.20M | $-106.20M | $-55.70M | $-57.70M | $-79.80M | $-64.50M | $-36.20M | $11.00M | $23.60M |
Annual Cash Flow
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
---|---|---|---|---|---|
Net Income | $35.60M | $139.10M | $133.00M | $93.10M | $28.70M |
Depreciation and Amortization | $43.50M | $39.30M | $40.10M | $42.70M | $46.00M |
Deferred Income Tax | $-39.30M | $3.60M | $-5.50M | $6.40M | $-2.50M |
Stock Based Compensation | $8.50M | $8.00M | $6.70M | $4.40M | $5.80M |
Change in Working Capital | $- | $20.60M | $-90.10M | $-48.10M | $50.10M |
Accounts Receivables | $- | $-12.60M | $-55.50M | $-31.40M | $10.10M |
Inventory | $- | $83.00M | $-98.50M | $-62.00M | $25.50M |
Accounts Payables | $-4.50M | $-26.90M | $54.20M | $90.20M | $-45.90M |
Other Working Capital | $-6.90M | $-22.90M | $9.70M | $-44.90M | $60.40M |
Other Non Cash Items | $136.20M | $-3.30M | $-2.50M | $-5.30M | $17.80M |
Net Cash Provided by Operating Activities | $184.50M | $207.30M | $81.70M | $93.20M | $145.90M |
Investments in Property Plant and Equipment | $-41.40M | $-77.20M | $-42.30M | $-39.10M | $-29.70M |
Acquisitions Net | $-200.00K | $-34.70M | $2.00M | $3.00M | $100.00K |
Purchases of Investments | $- | $- | $- | $- | $- |
Sales Maturities of Investments | $- | $- | $- | $- | $- |
Other Investing Activities | $-20.40M | $100.00K | $-1.80M | $-100.00K | $-100.00K |
Net Cash Used for Investing Activities | $-62.00M | $-111.80M | $-42.10M | $-36.20M | $-29.70M |
Debt Repayment | $- | $-2.30M | $-100.00K | $-600.00K | $-61.10M |
Common Stock Issued | $2.10M | $900.00K | $2.20M | $10.10M | $2.20M |
Common Stock Repurchased | $-700.00K | $-1.10M | $-5.90M | $-800.00K | $-2.10M |
Dividends Paid | $-38.80M | $-35.10M | $-31.70M | $-28.80M | $-25.60M |
Other Financing Activities | $2.10M | $-1.40M | $1.80M | $100.00K | $-200.00K |
Net Cash Used Provided by Financing Activities | $-35.30M | $-39.00M | $-33.70M | $-20.00M | $-86.80M |
Effect of Forex Changes on Cash | $-1.70M | $100.00K | $-600.00K | $-500.00K | $200.00K |
Net Change in Cash | $85.50M | $56.60M | $5.30M | $36.50M | $29.60M |
Cash at End of Period | $289.20M | $203.70M | $147.10M | $141.80M | $105.30M |
Cash at Beginning of Period | $203.70M | $147.10M | $141.80M | $105.30M | $75.70M |
Operating Cash Flow | $184.50M | $207.30M | $81.70M | $93.20M | $145.90M |
Capital Expenditure | $-41.40M | $-62.10M | $-42.30M | $-39.10M | $-29.70M |
Free Cash Flow | $143.10M | $130.10M | $39.40M | $54.10M | $116.20M |
Cash Flow Charts
Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | $-70.40M | $33.40M | $31.20M | $41.40M | $37.80M | $39.20M | $28.90M | $33.20M | $25.50M | $38.70M | $32.30M | $36.50M | $23.90M | $23.40M | $22.40M | $23.40M | $22.60M | $12.70M | $-39.70M | $33.10M |
Depreciation and Amortization | $10.90M | $11.10M | $11.10M | $10.40M | $10.20M | $9.90M | $9.90M | $9.30M | $9.20M | $10.10M | $10.30M | $10.50M | $11.80M | $10.30M | $10.30M | $10.30M | $10.70M | $11.10M | $12.20M | $12.00M |
Deferred Income Tax | $-39.90M | $-100.00K | $-100.00K | $800.00K | $3.10M | $-600.00K | $-100.00K | $1.20M | $-6.10M | $-400.00K | $100.00K | $900.00K | $-1.60M | $200.00K | $7.70M | $100.00K | $800.00K | $2.30M | $-6.30M | $700.00K |
Stock Based Compensation | $2.10M | $2.20M | $2.10M | $2.10M | $2.10M | $2.00M | $2.00M | $1.90M | $2.00M | $1.50M | $1.50M | $1.70M | $-200.00K | $1.70M | $1.30M | $1.60M | $1.40M | $1.60M | $1.60M | $1.20M |
Change in Working Capital | $-32.70M | $13.40M | $-39.40M | $26.00M | $20.00M | $8.40M | $15.20M | $-23.00M | $48.40M | $-9.50M | $-51.10M | $-77.90M | $37.80M | $-32.00M | $-42.00M | $-11.90M | $23.40M | $28.90M | $41.20M | $-43.40M |
Accounts Receivables | $-29.20M | $-21.00M | $15.00M | $39.50M | $-42.10M | $38.90M | $-200.00K | $-6.00M | $14.60M | $-70.10M | $-9.20M | $-52.90M | $74.40M | $-25.40M | $-37.90M | $-30.70M | $74.40M | $-22.70M | $74.80M | $-7.90M |
Inventory | $5.80M | $200.00K | $-11.80M | $-6.00M | $41.00M | $23.00M | $9.90M | $9.10M | $14.10M | $-24.30M | $-58.80M | $-29.50M | $-4.90M | $-25.80M | $-25.80M | $-5.50M | $22.20M | $5.40M | $2.90M | $-5.00M |
Accounts Payables | $9.10M | $42.00M | $-35.90M | $-19.70M | $30.30M | $-19.50M | $-9.70M | $-28.00M | $15.30M | $18.00M | $19.00M | $1.90M | $31.60M | $19.30M | $19.10M | $20.20M | $18.20M | $15.50M | $-43.60M | $-36.00M |
Other Working Capital | $-18.40M | $-7.80M | $-6.70M | $12.20M | $-9.20M | $-34.00M | $15.20M | $1.90M | $4.40M | $66.90M | $-2.10M | $2.60M | $-63.30M | $-100.00K | $2.60M | $4.10M | $-91.40M | $30.70M | $7.10M | $5.50M |
Other Non Cash Items | $155.70M | $13.80M | $56.50M | $9.00M | $-800.00K | $-800.00K | $-900.00K | $-800.00K | $-600.00K | $-600.00K | $-600.00K | $-700.00K | $-2.90M | $-800.00K | $-800.00K | $-800.00K | $-700.00K | $-1.10M | $20.80M | $-1.20M |
Net Cash Provided by Operating Activities | $25.70M | $73.80M | $4.40M | $80.60M | $72.40M | $58.10M | $55.00M | $21.80M | $78.40M | $39.80M | $-7.50M | $-29.00M | $68.80M | $2.80M | $-1.10M | $22.70M | $58.20M | $55.50M | $29.80M | $2.40M |
Investments in Property Plant and Equipment | $-20.80M | $-11.80M | $-15.30M | $-14.40M | $-21.20M | $-16.70M | $-17.30M | $-22.00M | $-15.20M | $-9.70M | $-9.00M | $-8.40M | $-11.70M | $-7.90M | $-9.20M | $-10.30M | $-8.00M | $-7.10M | $-6.80M | $-7.80M |
Acquisitions Net | $- | $- | $500.00K | $300.00K | $-34.90M | $100.00K | $200.00K | $- | $- | $2.00M | $- | $- | $2.50M | $100.00K | $400.00K | $- | $- | $- | $- | $- |
Purchases of Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Sales Maturities of Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Other Investing Activities | $200.00K | $-700.00K | $-4.30M | $-3.60M | $-4.20M | $-100.00K | $-200.00K | $-4.30M | $100.00K | $-1.90M | $- | $- | $2.50M | $100.00K | $300.00K | $- | $-8.00M | $- | $- | $- |
Net Cash Used for Investing Activities | $-20.60M | $-12.50M | $-14.80M | $-14.10M | $-56.10M | $-16.70M | $-17.30M | $-22.00M | $-15.10M | $-9.60M | $-9.00M | $-8.40M | $-9.20M | $-7.80M | $-8.90M | $-10.30M | $-8.00M | $-7.10M | $-6.80M | $-7.80M |
Debt Repayment | $- | $- | $- | $- | $-2.30M | $- | $- | $- | $- | $- | $- | $-100.00K | $-100.00K | $-200.00K | $-100.00K | $-200.00K | $-200.00K | $-40.30M | $-20.30M | $-300.00K |
Common Stock Issued | $1.30M | $-800.00K | $100.00K | $700.00K | $200.00K | $- | $- | $700.00K | $100.00K | $- | $200.00K | $1.90M | $8.10M | $300.00K | $1.20M | $500.00K | $1.00M | $400.00K | $100.00K | $700.00K |
Common Stock Repurchased | $- | $- | $-300.00K | $-400.00K | $-100.00K | $- | $-700.00K | $-300.00K | $-900.00K | $-2.30M | $-1.80M | $-900.00K | $- | $- | $-200.00K | $-600.00K | $- | $- | $- | $-2.10M |
Dividends Paid | $-19.80M | $- | $-19.00M | $- | $-17.90M | $- | $-17.20M | $- | $-16.10M | $- | $-15.60M | $- | $-14.80M | $- | $-14.00M | $- | $-12.80M | $- | $-12.80M | $- |
Other Financing Activities | $700.00K | $1.40M | $300.00K | $- | $-300.00K | $200.00K | $-1.30M | $- | $-100.00K | $1.90M | $- | $- | $- | $- | $100.00K | $- | $- | $-300.00K | $- | $100.00K |
Net Cash Used Provided by Financing Activities | $-17.80M | $1.40M | $-19.20M | $300.00K | $-20.10M | $200.00K | $-19.20M | $400.00K | $-17.00M | $-400.00K | $-17.20M | $900.00K | $-6.80M | $100.00K | $-13.00M | $-300.00K | $-12.00M | $-40.20M | $-33.00M | $-1.60M |
Effect of Forex Changes on Cash | $-1.90M | $900.00K | $-300.00K | $-400.00K | $300.00K | $-300.00K | $-100.00K | $200.00K | $300.00K | $-700.00K | $-500.00K | $300.00K | $-200.00K | $-300.00K | $400.00K | $-400.00K | $500.00K | $200.00K | $100.00K | $-600.00K |
Net Change in Cash | $-14.60M | $63.60M | $-29.90M | $66.40M | $-3.50M | $41.30M | $18.40M | $400.00K | $46.60M | $29.10M | $-34.20M | $-36.20M | $52.60M | $-5.20M | $-22.60M | $11.70M | $38.70M | $8.40M | $-9.90M | $-7.60M |
Cash at End of Period | $289.20M | $303.80M | $240.20M | $270.10M | $203.70M | $207.20M | $165.90M | $147.50M | $147.10M | $100.50M | $71.40M | $105.60M | $141.80M | $89.20M | $94.40M | $117.00M | $105.30M | $66.60M | $58.20M | $68.10M |
Cash at Beginning of Period | $303.80M | $240.20M | $270.10M | $203.70M | $207.20M | $165.90M | $147.50M | $147.10M | $100.50M | $71.40M | $105.60M | $141.80M | $89.20M | $94.40M | $117.00M | $105.30M | $66.60M | $58.20M | $68.10M | $75.70M |
Operating Cash Flow | $25.70M | $73.50M | $4.40M | $80.60M | $72.40M | $58.10M | $55.00M | $21.80M | $78.40M | $39.80M | $-7.50M | $-29.00M | $68.80M | $2.80M | $-1.10M | $22.70M | $58.20M | $55.50M | $29.80M | $2.40M |
Capital Expenditure | $-20.80M | $-11.80M | $-15.30M | $-14.40M | $-21.20M | $-16.70M | $-17.30M | $-22.00M | $-15.20M | $-9.70M | $-9.00M | $-8.40M | $-11.70M | $-7.90M | $-9.20M | $-10.30M | $-8.00M | $-7.10M | $-6.80M | $-7.80M |
Free Cash Flow | $4.90M | $61.70M | $-10.90M | $66.20M | $51.20M | $41.40M | $37.70M | $-200.00K | $63.20M | $30.10M | $-16.50M | $-37.40M | $57.10M | $-5.10M | $-10.30M | $12.40M | $50.20M | $48.40M | $23.00M | $-5.40M |
Innospec Dividends
Explore Innospec's dividend history, including dividend yield, payout ratio, and historical payments.
Dividend Yield
1.41%
Dividend Payout Ratio
108.99%
Dividend Paid & Capex Coverage Ratio
2.30x
Innospec Dividend History
Dividend | Adjusted Dividend | Date | Record Date | Payment Date | Declaration Date |
---|---|---|---|---|---|
$0.79 | $0.79 | November 18, 2024 | November 18, 2024 | November 26, 2024 | November 05, 2024 |
$0.76 | $0.76 | May 17, 2024 | May 20, 2024 | May 31, 2024 | |
$0.72 | $0.72 | November 17, 2023 | November 20, 2023 | November 27, 2023 | November 06, 2023 |
$0.69 | $0.69 | May 19, 2023 | May 22, 2023 | May 31, 2023 | May 03, 2023 |
$0.65 | $0.65 | November 18, 2022 | November 21, 2022 | November 28, 2022 | November 08, 2022 |
$0.63 | $0.63 | May 16, 2022 | May 17, 2022 | May 26, 2022 | May 03, 2022 |
$0.59 | $0.59 | November 15, 2021 | November 16, 2021 | November 24, 2021 | November 02, 2021 |
$0.57 | $0.57 | May 14, 2021 | May 17, 2021 | May 26, 2021 | May 04, 2021 |
$0.52 | $0.52 | November 16, 2020 | November 17, 2020 | November 25, 2020 | November 03, 2020 |
$0.52 | $0.52 | May 15, 2020 | May 18, 2020 | May 26, 2020 | April 28, 2020 |
$0.52 | $0.52 | November 18, 2019 | November 19, 2019 | November 27, 2019 | November 01, 2019 |
$0.5 | $0.5 | May 20, 2019 | May 21, 2019 | May 30, 2019 | May 06, 2019 |
$0.45 | $0.45 | November 16, 2018 | November 19, 2018 | November 29, 2018 | November 02, 2018 |
$0.44 | $0.44 | May 18, 2018 | May 21, 2018 | May 31, 2018 | May 06, 2018 |
$0.39 | $0.39 | November 15, 2017 | November 16, 2017 | November 27, 2017 | November 03, 2017 |
$0.38 | $0.38 | May 18, 2017 | May 22, 2017 | May 31, 2017 | May 10, 2017 |
$0.34 | $0.34 | November 10, 2016 | November 15, 2016 | November 24, 2016 | November 03, 2016 |
$0.33 | $0.33 | May 12, 2016 | May 16, 2016 | May 25, 2016 | May 04, 2016 |
$0.31 | $0.31 | November 12, 2015 | November 16, 2015 | November 25, 2015 | November 04, 2015 |
$0.3 | $0.3 | May 14, 2015 | May 18, 2015 | May 27, 2015 | May 06, 2015 |
Innospec News
Read the latest news about Innospec, including recent articles, headlines, and updates.
Innospec Approves New $50MM Share Repurchase Program
ENGLEWOOD, Colo., March 10, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announces that its Board of Directors has approved a new $50 million share repurchase program. The company's prior $50 million share repurchase program expired in the first quarter of 2025.

Innospec Well-Placed To Navigate Uncertain Times
Innospec generated solid Q4 results relative to comparable specialty chemical companies, including strong volume growth in Fuel Specialties and Performance Chemicals and healthy margins. The outlook for 2025 is shakier, but diesel fuel demand should remain positive and further high-grading of the Performance Chemicals portfolio can offset some risk of weaker consumer spending. Oilfield is a harder call, given the company's exposure to more volatile trends in Latin America and the frac market.

Innospec and UNESCO IESALC Sign Partnership to Increase Indigenous Participation in Stem Education and Initiatives in Brazil
ENGLEWOOD, Colo., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Innospec (NASDAQ: IOSP), a leading global specialty chemicals company, today announces a partnership with UNESCO International Institute for Higher Education (IESALC) to launch an educational program aimed at improving access to STEM (Science, Technology, Engineering, and Mathematics) education for indigenous students in Brazil. The main outcome of the project will consist of a course on sustainable development and STEM – co-designed by indigenous and non-indigenous students and researchers—integrating indigenous knowledge and science applied to sustainability practices to empower diverse voices in STEM education. This initiative will directly train 40 indigenous students, with its ripple effects benefiting an additional 200 individuals.

Innospec, Inc. (IOSP) Q4 2024 Earnings Call Transcript
Innospec, Inc. (NASDAQ:IOSP ) Q4 2024 Earnings Conference Call February 19, 2025 9:00 AM ET Company Participants David Jones - General Counsel & Chief Compliance Officer Patrick Williams - President & CEO Ian Cleminson - EVP & CFO Conference Call Participants Jon Tanwanteng - CJS Securities. Operator Good day and thank you for standing by.

Innospec Schedules Fourth Quarter 2024 Earnings Release and Conference Call
ENGLEWOOD, Colo., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced that it will release fourth quarter 2024 earnings results on Tuesday, February 18, 2025 after market close. Following the release of its results, Patrick S. Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer, will host an interactive conference call on Wednesday, February 19, 2025, at 9:00 a.m. ET.

8 Upcoming Dividend Increases
Eight dividend contenders are increasing their dividends this week, with an average increase of 7.1% and a median of 4.4%. My strategy focuses on buying, holding, and adding to companies with consistent dividend growth and outperformance against benchmarks. The list is derived from merging U.S. Dividend Champions data with NASDAQ's upcoming dividend information, ensuring at least five years of dividend growth.

Innospec, Inc. (IOSP) Q3 2024 Earnings Call Transcript
Innospec, Inc. (NASDAQ:IOSP ) Q3 2024 Earnings Conference Call November 6, 2024 10:00 AM ET Company Participants David Jones - General Counsel & Chief Compliance Officer Ian Cleminson - EVP & CFO Patrick Williams - President & CEO Conference Call Participants Mike Harrison - Seaport Research Partners Jon Tanwanteng - CJS Securities David Silver - CL King & Associates Operator Good day, and thank you for standing by. Welcome to the Innospec Third Quarter 2024 Earnings Release Conference Call.

Innospec Reports Third Quarter 2024 Financial Results
Performance Chemicals and Fuel Specialties operating income up double digits with margin expansion As expected, Oilfield Services results remain impacted by lower production chemical activity $73.5 million cash generated from operations; Net cash improves to $303.8 million GAAP EPS $1.33 and adjusted non-GAAP EPS $1.35 Dividend for full year increased by 10 percent ENGLEWOOD, Colo., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced its financial results for the third quarter ended September 30, 2024 and declared a semi-annual dividend of 79 cents per common share for the second half of 2024, which will be paid on November 26, 2024 to shareholders of record as of November 18, 2024.

Innospec Schedules Third Quarter 2024 Earnings Release and Conference Call
ENGLEWOOD, Colo., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced that it will release third quarter 2024 earnings results on Tuesday, November 5, 2024 after market close. Following the release of its results, Patrick S. Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer, will host an interactive conference call on Wednesday, November 6, 2024, at 10:00 a.m. ET.

Innospec Publishes 2023 Sustainability Report
ENGLEWOOD, Colo., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Innospec (NASDAQ: IOSP) today announced the publication of its 2023 Sustainability Report. This marks the significant milestone of 25 years of reporting on the company's progress and ongoing commitment to sustainable business practices.

Innospec Reports Second Quarter 2024 Financial Results
Performance Chemicals operating income more than doubles on personal care growth Fuel Specialties operating income up double digits with margin expansion As expected, Oilfield Services results impacted by lower production chemical activity Debt-free balance sheet with over $240 million in net cash GAAP EPS $1.24 and adjusted non-GAAP EPS $1.39 ENGLEWOOD, Colo., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced its financial results for the second quarter ended June 30, 2024.

Innospec Schedules Second Quarter 2024 Earnings Release and Conference Call
ENGLEWOOD, Colo., July 02, 2024 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced that it will release second quarter 2024 earnings results on Tuesday, August 6, 2024 after market close. Following the release of its results, Patrick S. Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer, will host an interactive conference call on Wednesday, August 7, 2024, at 10:00 a.m. ET.

Innospec Achieves Gold Rating in EcoVadis Sustainability Assessment for the Fourth Consecutive Time
ENGLEWOOD, Colo., June 24, 2024 (GLOBE NEWSWIRE) -- Innospec (NASDAQ: IOSP) has been awarded a Gold rating in sustainability performance by EcoVadis, a leading provider of third-party sustainability evaluations. Achieving a Gold rating ranks Innospec in the top 5% of all companies rated in our sector, globally.

Innospec and IJM Announce New Partnership to Strengthen Protection for Palm Oil Workers in Southeast Asia
ENGLEWOOD, Colo., June 05, 2024 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP), a global leader in specialty chemicals, is proud to announce that its Performance Chemicals business has entered into a social partnership with International Justice Mission (IJM). IJM is a global nonprofit organization working with local authorities in 33 communities to combat modern slavery and violence against women, rescuing and restoring victims, holding perpetrators accountable, and strengthening the local public justice systems to build a safe future that lasts.

Innospec Reports First Quarter 2024 Financial Results
Strong contribution from Performance Chemicals drives operating income growth of 23 percent $80.6 million cash generated from operations; Net cash improves to $270.1 million Dividend increased by 10 percent; Strong debt-free balance sheet GAAP EPS of $1.65 and adjusted non-GAAP EPS of $1.75 ENGLEWOOD, Colo., May 09, 2024 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced its financial results for the first quarter ended March 31, 2024.

Similar Companies
Northern Technologies International Corporation
NTIC
Price: $11.15
Market Cap: $105.60M
Related Metrics
Explore detailed financial metrics and analysis for IOSP.